Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

Step into a world where comfort meets style! 🌟 Ultra-soft furnishings are taking over our spaces, making every corner feel ...

UBS remains bullish on Eli Lilly’s future thanks to surging demand for its obesity and diabetes treatments. UBS predicts Zepbound sales could exceed market expectations by roughly 15%. Meanwhile, ...

Eli Lilly & Company (NYSE:LLY) ranks among the best set-it-and-forget-it stocks to buy. On June 27, UBS kept its Buy rating ...

CVS says the decision to cover Wegovy and exclude Zepbound is "forcing the drug manufacturers to compete with one another" and will encourage both Eli Lilly and Novo Nordisk to lower prices for their ...

The Siren’s Curse left riders in a vertical position for about 10 minutes on June 28, the Akron Beacon Journal reported.

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

A Detroit man’s last wish was fulfilled as a helicopter dropped money and rose petals over part of the Motor City. Darrell ...

CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.

CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.